Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants

Krishnan, A. V., Freniere, V., Sahni, R., Vargas Chaves, D. P., Krishnan, S. S., Savva, D., & Krishnan, U. S. (2024). Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants. Children, 11(6), 703. https://doi.org/10.3390/children11060703
Authors:
Anand T. Krishnan
Victoria Freniere
Rakesh Sahni
Diana P. Vargas Chaves
Sankaran Krishnan
Dimitrios Savva
Usha Krishnan
Affiliated Authors:
Anand T. Krishnan
Victoria Freniere
Rakesh Sahni
Diana P. Vargas Chaves
Dimitrios Savva
Usha Krishnan
Columbia Affiliation:
Subjects:
Diagnosis and Treatment of Pulmonary Hypertension (OpenAlex Topic)
Neonatal Lung Development and Respiratory Morbidity (OpenAlex Topic)
Diagnosis and Treatment of Heart Failure (OpenAlex Topic)
Author Keywords:
continuous iloprost
infant
neonate
outcome
pulmonary hypertension
elink
Publication Type:
Article
Unique ID:
10.3390/children11060703
PMID:
38929282
DOI:
10.3390/children11060703
Journal:
Children
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: